Immune Thrombocytopenia Associated with Mycoplasma pneumoniae Infection

Catarina Gouveia1, Vasco Evangelista1, Raquel Almeida1

  • 1Beatriz Ângelo Hospital, Loures, Portugal.

Insights

Immune thrombocytopenia (ITP) secondary to Mycoplasma pneumoniae infection is rare and often severe. This case highlights the challenging clinical course and treatment of this condition.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Immunology

Background:

  • Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts.
  • Mycoplasma pneumoniae infection is a common respiratory pathogen.
  • ITP secondary to Mycoplasma pneumoniae infection is a rare but serious complication.

Purpose of the Study:

  • To report a case of severe ITP secondary to Mycoplasma pneumoniae infection.
  • To describe the clinical features, therapy, and outcome of this rare condition.
  • To discuss the association between Mycoplasma pneumoniae infection and ITP severity.

Main Methods:

  • Case report of a young male patient.
  • Clinical diagnosis of severe ITP.
  • Review of clinical features, therapeutic interventions, and patient outcome.

Main Results:

  • The patient presented with severe ITP.
  • The condition was secondary to Mycoplasma pneumoniae infection.
  • The clinical course was severe and refractory to initial treatment.

Conclusions:

  • ITP associated with Mycoplasma pneumoniae infection is rare.
  • This specific type of ITP often presents with a severe and refractory clinical course.
  • The efficacy of anti-Mycoplasma antibiotic therapy on ITP prognosis remains uncertain.

Related Concept Videos

What is the Immune System?01:38

What is the Immune System?

Overview
127.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
871
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.9K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
83.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
810
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K